Founded in 2009 by Thomas Siebel, C3.ai's core purpose has always been to deliver AI solutions to enterprises. Its value ...

C3.ai, Inc. (AI) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some ...

Pegcetacoplan has been approved for the treatment of C3 glomerulopathy or primary immune complex membranoproliferative ...

Software company C3.ai Inc. is looking for a new chief executive officer after Tom Siebel said he intends to step aside due ...

What To Know: C3.ai said it initiated a search for a new CEO to replace Thomas Siebel, who is battling health issues. The ...

AI stock fell on Thursday after software maker C3.ai said its chief executive, Thomas Siebel, will step down for health ...

C3.ai announced today that CEO Tom Siebel would be stepping down and that the company was in the process of looking for its ...

Unlike some German brands, French carmaker Citroen leads from the front and is not afraid to mix it up when it comes to design.

C3 AI founder and Chief Executive Officer Tom Siebel today announced that he will step down because of health issues.

Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of C3.ai's market ...

Pegcetacoplan inhibits C3 activation by binding to C3 and its activation fragment C3b, thereby reducing C3 glomerular fragment deposition in patients with C3G and primary IC-MPGN.

C3 Bullion, a pioneer in next-generation gold investment solutions, has launched its India operations, bringing its flagship ...